DOJ Policy Revision Raises Hopes of More Intervening Dismissals, but We’ve Heard This Tune Before

On Sept. 18, the U.S. Department of Justice (DOJ) issued a press release describing two modifications to the DOJ Policy Manual. I have seen many people express the opinion that the revisions are good news, but it is worth noting that the headline selected by the DOJ is that the rationale for the revisions was to “strengthen False Claims Act enforcement.” 

The source of the optimism is that the press release explains that “the Department of Justice should enforce the law, not make law through enforcement,” citing Associate Attorney General Stanley E. Woodward, Jr.

One of the revisions reinstates an on-again, off-again policy that started back in 2017 and says sub-regulatory guidance cannot impose a legal obligation that wasn’t created by a statute or regulation. You may recall our talking about the Brand memo many years ago, authored by then-Deputy Associate Attorney General Rachel Brand. That memo instructed affirmative civil enforcement (ACE) lawyers, known within DOJ as ACE attorneys, not to bring a case based on language found in manuals. 

Former Attorney General Merrick Garland later reversed the policy, and Pam Bondi reimplemented it. I have found those flips somewhat puzzling, given the fact that the U.S. Supreme Court has essentially forbidden the use of manuals as the sole basis of a False Claims Act (FCA) case in the Allina decision issued in June 2019.  

It is the second revision that is inspiring the most optimism. The press release describes it as making it “clear that the Department should consider exercising its dismissal authority when it declines to intervene in a qui tam action and, where it does not seek dismissal, revisit that assessment as appropriate during litigation.” 

When a relator brings an FCA case, the government investigates (while the statute allows 60 days for this review, it often takes years). Historically, the government has either intervened, taking over the case, or declined, allowing the relator to continue. As of late, the DOJ has often taken a third option that does not seem authorized by the law, making a decision “not to intervene at this time.” That always felt like a declination to me. But there has always been another option: the government can intervene to affirmatively dismiss the case. I was lucky enough to have that happen once, way back in the 1990s. Shortly thereafter, the DOJ decided it would never intervene to dismiss a case. But in 2017, Michael Granston announced that the DOJ would resume the practice of dismissing cases when they were baseless or could result in bad precedent. Since that policy changed nearly a decade ago, interventions to dismiss have been incredibly rare. While there are around 1,300 FCA cases each year, I do not believe that the interventions to dismiss reach double digits. Will the new policy change that? I certainly hope so, but I have learned a lesson by getting pretty excited about that 2017 memo, only to have my hopes crushed.

To illustrate that lesson, I am going to refer to Michael Sembello’s hit from the Flashdance soundtrack, Maniac. Normally, my song references focus on the lyrics. But in this case, I am focused on the title, and in particular, its odd pronunciation. Why is “maniac” pronounced MAY-nee-ack? If you get your nails worked up, it isn’t a (MAY-nee-cure), and if you use numbers nefariously, you are not (MAY-nip-ulating) the data. Shouldn’t it be (MAN-i-ack)? There is a lesson here. Just because something is written down doesn’t mean it will happen exactly the way you expect. I really hope that the revised DOJ policy will result in more interventions for dismissal, but I have had high hopes before. So, while “she’s dancing like she’s never danced before,” I won’t be just yet! Which is probably better for everyone!

EDITOR’S NOTE:

The opinions expressed in this article are solely those of the author and do not necessarily represent the views or opinions of MedLearn Media. We provide a platform for diverse perspectives, but the content and opinions expressed herein are the author’s own. MedLearn Media does not endorse or guarantee the accuracy of the information presented. Readers are encouraged to critically evaluate the content and conduct their own research. Any actions taken based on this article are at the reader’s own discretion.

Facebook
Twitter
LinkedIn

David M. Glaser, Esq.

David M. Glaser is a shareholder in Fredrikson & Byron's Health Law Group. David assists clinics, hospitals, and other health care entities negotiate the maze of healthcare regulations, providing advice about risk management, reimbursement, and business planning issues. He has considerable experience in healthcare regulation and litigation, including compliance, criminal and civil fraud investigations, and reimbursement disputes. David's goal is to explain the government's enforcement position, and to analyze whether this position is supported by the law or represents government overreaching. David is a member of the RACmonitor editorial board and is a popular guest on Monitor Mondays.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

One Chart, Five Truths: How CDI Prevents the Same Diagnosis from Becoming Five Different Outcomes

What happens when everyone reviews the same chart, but reaches a different conclusion? In this case-based clinical documentation integrity (CDI) webcast, Penny Jefferson examines how documentation involving clinical support, timing, causation, linkage, and terminology can produce very different outcomes for ICD-10 coding, reimbursement, quality, risk adjustment, medical necessity, denials, and compliance. Using cases involving postoperative respiratory failure, severe malnutrition, and encephalopathy, you’ll learn the practical CLEAR framework to help attendees learn to evaluate whether a diagnosis is codeable, consistent, specific, reportable, and ultimately defensible across the different teams and systems that rely on the medical record.

September 30, 2026

Mastering Spinal Fusion Coding for Inpatient Facilities: ICD-10-PCS Precision, Documentation, and MS-DRG Impact

Spinal fusion cases are among the most complex inpatient procedures to code, where even minor ICD-10-PCS errors can affect MS-DRG assignment, reimbursement, compliance, and audit outcomes. This practical webcast provides a step-by-step framework for interpreting operative reports, assigning accurate ICD-10-PCS codes, recognizing documentation gaps, and confidently coding complex fusion procedures. You’ll leave with practical tools that improve coding accuracy, reduce denials and audit risk, and strengthen documentation-driven reimbursement decisions.

July 29, 2026

AI, Audits, and the Future of the Revenue Cycle

Artificial intelligence is rapidly transforming healthcare revenue cycle operations, from coding and auditing to compliance and denials. Join industry leaders Pam Warren (MaineHealth) and Raemarie Jimenez (AAPC) for a live fireside chat exploring how AI is changing workflows, workforce roles, payer-provider dynamics, and compliance risk—and what organizations should be doing now to prepare.

Webcast Only Available On ICD10monitor Subscription – Subscribe Below

June 17, 2026

Trending News

Featured Webcasts

Radiation Oncology Fundamentals: Coding, Billing & Compliance for Hospital Outpatient & Professional Services

Join Michael Calahan, PA, MBA for this radiation oncology coding and compliance webcast as he explains the fundamentals of coding, billing, reporting, and documentation for hospital outpatient and professional services. Learn how the 2026 radiation therapy coding changes affect current practices, how to distinguish technical and professional services, and how to address bundling, units, frequency, modifiers, and documentation requirements. Michael will also help you identify radiation oncology coding and billing vulnerabilities that could lead to denials, overpayments, repayment demands, or federal audit exposure.

October 20, 2026

CMS Compliance & Audit Readiness Bundle

Get two essential perspectives on CMS compliance for $199.

The Two-Midnight Rule helps you navigate short-stay admissions, patient status, and evolving 2026-2027 requirements, while CMS CRUSH explores the next wave of program integrity, payment oversight, and data-driven scrutiny.

Two RACmonitor webcasts. One practical approach to preparing for increased CMS oversight.

September 20, 2026

Preparing for 2027: Inpatient & Outpatient Policy Changes for Case Management and Utilization Review

The 2027 CMS policy changes will impact case management, utilization review, reimbursement, and patient status decision-making long before they officially take effect. Join nationally recognized physician advisor Dr. Ronald Hirsch as he explains the finalized and proposed inpatient and outpatient rule changes, expanding bundled payment initiatives, payment updates, and evolving payer expectations. Gain practical guidance to help your organization prepare early, strengthen compliance, reduce reimbursement risk, and confidently navigate the transition to 2027.

September 17, 2026

Trending News

Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →

Have a Medicare regulation question you’d love Dr. Hirsch to answer? Now is your chance! CLICK HERE to learn more→

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

This Memorial Day, we honor those who gave all for our freedom. Take 20% off sitewide through May 29 with code MEMORIAL26 at checkout

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24